- Home
- ACIW vs ELAN Comparison
ACIW vs ELAN Comparison
Compare ACIW & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIW
- ELAN
- Stock Information
- Founded
- ACIW 1975
- ELAN 1954
- Country
- ACIW United States
- ELAN United States
- Employees
- ACIW N/A
- ELAN N/A
- Industry
- ACIW EDP Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- ACIW Technology
- ELAN Health Care
- Exchange
- ACIW Nasdaq
- ELAN Nasdaq
- Market Cap
- ACIW 5.8B
- ELAN 5.4B
- IPO Year
- ACIW 1995
- ELAN 2018
- Fundamental
- Price
- ACIW $54.28
- ELAN $10.42
- Analyst Decision
- ACIW Buy
- ELAN Buy
- Analyst Count
- ACIW 5
- ELAN 6
- Target Price
- ACIW $53.33
- ELAN $15.00
- AVG Volume (30 Days)
- ACIW 624.0K
- ELAN 3.8M
- Earning Date
- ACIW 04-29-2025
- ELAN 05-07-2025
- Dividend Yield
- ACIW N/A
- ELAN N/A
- EPS Growth
- ACIW 70.55
- ELAN N/A
- EPS
- ACIW 1.91
- ELAN 0.68
- Revenue
- ACIW $1,594,288,000.00
- ELAN $4,439,000,000.00
- Revenue This Year
- ACIW $8.58
- ELAN $3.20
- Revenue Next Year
- ACIW $7.16
- ELAN $4.26
- P/E Ratio
- ACIW $28.26
- ELAN $15.12
- Revenue Growth
- ACIW 9.76
- ELAN 0.50
- 52 Week Low
- ACIW $31.19
- ELAN $10.03
- 52 Week High
- ACIW $59.71
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- ACIW 54.11
- ELAN 42.62
- Support Level
- ACIW $52.20
- ELAN $10.45
- Resistance Level
- ACIW $55.87
- ELAN $10.85
- Average True Range (ATR)
- ACIW 1.22
- ELAN 0.36
- MACD
- ACIW 0.23
- ELAN 0.03
- Stochastic Oscillator
- ACIW 69.19
- ELAN 40.10
About ACIW ACI Worldwide Inc.
ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.